Sponsored by
New Vaccine trial opens!
The long awaited phase 2 trial of the ICT-107 vaccine has now opened at JFK Medical Center in NJ.
The previous small phase 1 trial reported remarkable results: 80% Survival at 2 Years for newly diagnosed Glioblastoma Multiforme patients. This compares very favorably to the historic controls reported of about 26.5%
Click HERE for details on this trial.